Humidified high flow therapy with myAirvo 2 delivers warmed and humidified air/oxygen mixtures to the patient through a comfortable interface. It is designed for use in the home and long-term care facilities.
~ Storgaard et al 2018 ~ Nagata et al 2022
~ Nagata et al 2018 ~ Storgaard et al 2018
With NHF therapy, you can independently titrate flow and FiO2 to match your patient’s needs. The mechanisms of action differ from those of conventional therapies, as do the resulting physiological effects and clinical outcomes.
Mechanisms of NHF therapy are:
Note: the above mechanisms of action for nasal high flow apply to delivery through an Optiflow nasal cannula interface. The mechanisms of action differ when high flow is delivered through a tracheostomy or mask interface adapter
We value your privacy. Our websites and applications use cookies to function properly and securely.